4 August 2019 - Federal and state governments are refusing to fund the meningococcal B vaccine while the Pharmaceutical Benefits Advisory Committee rules it would only “save nine lives” and was not worth the $400 million cost.
Federal Health minister Greg Hunt and his NSW counterpart Brad Hazzard said yesterday uncertainty about the B-strain vaccine Bexsero’s effectiveness has prevented it from being added to the National Immunisation Program.
The B strain has caused the most cases of the infection among babies, children and teenagers in NSW.